Stock listing
Lang & Schwarz:A40DQJ Atara Biotherapeutics, Inc. Aktie
German listing (Lang & Schwarz) of Atara Biotherapeutics, Inc. · home listing NASDAQ:ATRA
Follow Atara Biotherapeutics, Inc. into a list and get an email when it puts out news.
Home listing price · NASDAQ:ATRA
$9.16 USD +0.20 (+2.2%)
Close on Oct 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:ATRA
- Day range
- $8.88 – $9.29 USDOct 20, 2026
- Volume
- 14,842 sharesOct 20, 2026
- Market cap
- $91.95M USDAt the close on Oct 20, 2026 · price × 10.04M shares outstanding
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:ATRA · Home | $9.16 USD | +0.20 (+2.2%) | 14,842 | $8.89 | $9.29 | $8.88 | $8.96 | Close on Oct 20, 2026 |
| LSE:0HIY | $9.14 USD | +0.04 (+0.4%) | 75 | $9.03 | $9.14 | $9.03 | $9.10 | Close on Oct 20, 2026 |
Daily closes
Last 3 months, Jul 20, 2026 – Oct 20, 2026 · NASDAQ:ATRA · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $9.16 | +0.20 | +2.2% | $8.89 | $9.29 | $8.88 | 14,842 | |
| $8.96 | -0.22 | -2.4% | $9.26 | $9.35 | $8.96 | 12,450 | |
| $9.18 | -0.47 | -4.9% | $9.65 | $9.905 | $9.18 | 19,493 | |
| $9.65 | +0.09 | +0.9% | $9.35 | $9.78 | $9.185 | 24,300 | |
| $9.56 | +0.255 | +2.7% | $9.29 | $9.99 | $9.20 | 39,511 | |
| $9.305 | -0.075 | -0.8% | $9.25 | $9.54 | $8.80 | 32,284 | |
| $9.38 | -0.10 | -1.1% | $9.42 | $9.58 | $8.99 | 26,836 | |
| $9.48 | +0.25 | +2.7% | $9.33 | $9.56 | $9.33 | 22,148 | |
| $9.23 | -0.14 | -1.5% | $9.42 | $9.42 | $8.82 | 28,942 | |
| $9.37 | -0.38 | -3.9% | $9.62 | $9.75 | $9.37 | 11,449 | |
| $9.75 | +0.35 | +3.7% | $9.41 | $9.79 | $9.05 | 47,600 | |
| $9.40 | -0.08 | -0.8% | $9.59 | $9.63 | $8.95 | 39,300 | |
| $9.48 | +1.02 | +12.1% | $8.46 | $9.675 | $8.25 | 85,700 | |
| $8.46 | -0.04 | -0.5% | $8.73 | $9.20 | $8.23 | 90,900 | |
| $8.50 | +0.45 | +5.6% | $8.08 | $8.71 | $7.83 | 29,300 | |
| $8.05 | -0.32 | -3.8% | $8.33 | $8.821 | $7.89 | 56,400 | |
| $8.37 | -0.44 | -5.0% | $8.69 | $8.705 | $8.336 | 23,500 | |
| $8.81 | +0.27 | +3.2% | $8.60 | $8.99 | $8.535 | 31,200 | |
| $8.54 | -0.02 | -0.2% | $8.60 | $8.86 | $8.33 | 20,800 | |
| $8.56 | -0.37 | -4.1% | $8.92 | $8.95 | $8.40 | 40,500 | |
| $8.93 | -0.45 | -4.8% | $9.30 | $9.60 | $8.93 | 27,300 | |
| $9.38 | -0.31 | -3.2% | $9.69 | $9.92 | $9.30 | 29,700 | |
| $9.69 | -0.02 | -0.2% | $9.73 | $10.19 | $9.60 | 37,800 | |
| $9.71 | -0.40 | -4.0% | $10.28 | $10.28 | $9.41 | 26,400 | |
| $10.11 | +0.67 | +7.1% | $9.50 | $10.37 | $9.07 | 116,700 | |
| $9.44 | +0.19 | +2.1% | $9.21 | $9.88 | $8.92 | 56,100 | |
| $9.25 | -0.13 | -1.4% | $9.09 | $9.71 | $9.07 | 50,800 | |
| $9.38 | -0.51 | -5.2% | $10.00 | $10.00 | $9.38 | 16,000 | |
| $9.89 | -0.02 | -0.2% | $9.94 | $9.94 | $9.52 | 23,200 | |
| $9.91 | -0.32 | -3.1% | $10.27 | $10.43 | $9.76 | 68,500 | |
| $10.23 | +0.47 | +4.8% | $10.60 | $11.33 | $10.23 | 106,900 | |
| $9.76 | +0.23 | +2.4% | $9.45 | $9.95 | $9.25 | 132,700 | |
| $9.53 | +0.09 | +1.0% | $9.49 | $9.53 | $9.00 | 25,300 | |
| $9.44 | +0.42 | +4.7% | $9.08 | $9.48 | $9.08 | 20,900 | |
| $9.02 | +0.12 | +1.3% | $8.96 | $9.18 | $8.80 | 51,900 | |
| $8.90 | -0.30 | -3.3% | $9.09 | $9.29 | $8.83 | 30,200 | |
| $9.20 | -0.05 | -0.5% | $9.18 | $9.21 | $8.90 | 15,300 | |
| $9.25 | -0.13 | -1.4% | $9.38 | $9.60 | $9.165 | 26,900 | |
| $9.38 | -0.46 | -4.7% | $9.65 | $9.84 | $9.38 | 63,700 | |
| $9.84 | +0.38 | +4.0% | $9.57 | $10.02 | $9.538 | 48,500 | |
| $9.46 | -0.24 | -2.5% | $9.57 | $9.66 | $9.31 | 24,000 | |
| $9.70 | +0.32 | +3.4% | $9.46 | $9.89 | $9.15 | 27,100 | |
| $9.38 | -0.22 | -2.3% | $9.60 | $9.74 | $9.14 | 28,000 | |
| $9.60 | +0.88 | +10.1% | $8.85 | $9.74 | $8.276 | 79,100 | |
| $8.72 | +0.36 | +4.3% | $8.34 | $8.90 | $8.34 | 29,500 | |
| $8.36 | +0.27 | +3.3% | $8.00 | $8.48 | $7.81 | 66,000 | |
| $8.09 | -0.42 | -4.9% | $8.51 | $8.51 | $7.99 | 66,200 | |
| $8.51 | -0.715 | -7.8% | $8.34 | $9.24 | $7.73 | 126,500 | |
| $9.225 | +0.285 | +3.2% | $8.88 | $9.43 | $8.70 | 90,000 | |
| $8.94 | +0.33 | +3.8% | $8.62 | $9.04 | $8.359 | 29,246 | |
| $8.61 | +0.16 | +1.9% | $8.42 | $8.80 | $8.09 | 45,333 | |
| $8.45 | +0.20 | +2.4% | $8.30 | $8.485 | $8.202 | 23,200 | |
| $8.25 | -0.29 | -3.4% | $8.60 | $8.645 | $8.09 | 22,900 | |
| $8.54 | -0.23 | -2.6% | $8.60 | $8.98 | $8.38 | 32,500 | |
| $8.77 | +0.22 | +2.6% | $8.55 | $9.11 | $8.55 | 42,300 | |
| $8.55 | +0.17 | +2.0% | $8.42 | $8.66 | $8.255 | 53,200 | |
| $8.38 | +0.21 | +2.6% | $8.17 | $8.67 | $7.86 | 34,500 | |
| $8.17 | +0.11 | +1.4% | $8.18 | $8.32 | $7.86 | 96,000 | |
| $8.06 | +0.25 | +3.2% | $7.74 | $8.25 | $7.57 | 39,800 | |
| $7.81 | +0.10 | +1.3% | $7.76 | $7.91 | $7.39 | 85,400 | |
| $7.71 | -0.19 | -2.4% | $8.06 | $8.331 | $7.65 | 62,700 | |
| $7.90 | -0.27 | -3.3% | $8.19 | $8.38 | $7.84 | 75,200 | |
| $8.17 | +0.045 | +0.6% | $7.92 | $8.36 | $7.81 | 46,500 | |
| $8.125 | -0.505 | -5.9% | $8.61 | $8.61 | $8.018 | 28,900 | |
| $8.63 | +0.34 | +4.1% | $8.37 | $8.68 | $8.07 | 48,400 | |
| $8.29 | -0.10 | -1.2% | $8.29 | $8.83 | $8.093 | 59,200 |
- Ticker
- Lang & Schwarz:A40DQJ
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- Lang & Schwarz
- Currency
- EUR
What changed lately
Calls
Replays
Atara Biotherapeutics (NASDAQ:ATRA) Q3 2023 Earnings Call
Wed, Nov 01, 2023 · 9:00 AM ET
Watch TranscriptAtara Biotherapeutics (NASDAQ:ATRA) Q3 2022 Earnings Call
Tue, Nov 08, 2022 · 4:30 PM ET
Watch TranscriptAtara Biotherapeutics (NASDAQ:ATRA) Q2 2022 Earnings Call
Mon, Aug 08, 2022 · 4:30 PM ET
Watch Transcript
Latest news
Atara Biotherapeutics Reports that the Resubmitted Tabelecleucel (Tab-cel®) Biologics License Application Has Been Accepted by the U.S. Food and Drug Administration
Oct 14, 2026
Closed $9.56 (+2.7%) on Oct 14, 2026
Atara Biotherapeutics Reports that the Tabelecleucel Biologics License Application Has Been Resubmitted to the U.S. Food and Drug Administration
Sep 30, 2026
Closed $8.50 (+5.6%) on Sep 30, 2026
Atara Biotherapeutics Announces Second Quarter 2026 Financial Results and Operational Progress
Aug 12, 2026
Closed $8.51 (-7.8%) on Aug 13, 2026
Rajani Dinavahi, MD, Appointed Chief Medical Officer of Ardelyx
Apr 1, 2026
Issued by another party
Decks
Q3 2024 Earnings Presentation
Earnings · 32 slides · Nov 12, 2024
H.C. Wainwright 26th Annual Global Investment Conference (September 2024)
Conference · 22 slides · Sep 9, 2024
42nd Annual J.P. Morgan Healthcare Conference (January 2024)
Conference · 18 slides · Jan 8, 2024
JP Morgan Healthcare Conference 2022
Conference · 26 slides · Jan 10, 2022
Atara Biotherapeutics, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 10 in the last 12 months · 123 in all · newest Oct 14, 2026 · oldest 2019
- Calls
- 6 calls with a replay · 6 with a transcript · latest Nov 1, 2023
- Decks
- 12 decks · latest Nov 12, 2024
Where Atara Biotherapeutics, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:ATRA · Home listing | NASDAQ | United States | USD |
| BOATS:ATRA | BOATS | United States | USD |
| LSE:0HIY | LSE | United Kingdom | USD |
| BX Swiss:ATRA | BX Swiss | Switzerland | CHF |
| gettex:AT20 | gettex | Germany | EUR |
| Frankfurt:AT20 | Frankfurt | Germany | EUR |
| Lang & Schwarz:A40DQJ · This page | Lang & Schwarz | Germany | EUR |
| Munich:AT20 | Munich | Germany | EUR |
| Stuttgart:AT20 | Stuttgart | Germany | EUR |
| Tradegate:AT20 | Tradegate | Germany | EUR |
Log in to ask 6ix AI your own questions about Atara Biotherapeutics, Inc.